Announcement PDF 22 October 2026 Results of Annual General Meeting Cryosite Limited (ACN 090 919 476) (ASX: CTE) (Cryosite or Company) advises that its Annual General Meeting was held today at 11.00 am AEDT. In accordance with Listing Rule 3.13.2 and section 251AA(2) of the Corporations Act 2001(Cth), the Company advises that details of the resolutions and the proxies received in respect of each resolution are set out in the attached summary Authorised for lodgement by the Board of the Company —END— About Cryosite Cryosite is a unique Australian company and a world-class specialist in providing outsourced clinical trial and biological depot services. Established in 2000, Cryosite is highly experienced in clinical trial logistics. Our team is comprised of highly qualified scientists and clinical trials experts who ensure complex clinical trials are conducted with seamless efficiency and safety. We manage the importation, receipt, storage, distribution and reverse logistics of specialised ambient, cold, frozen, ultra-frozen, liquid nitrogen clinical trial, pharmaceutical and biological products. Cryosite’s third party depot services are professional, reliable and compliant; our people are experts in their respective fields and are approachable, ethical and responsive to clients’ needs. To learn more, please visit our website or Cryosite’s Investor Hub. 13a Ferndell Street South Granville, NSW, 2142 Building Area: ~1,800sqm GMP, GWP licenced Services include Clinical Trial and Biological: • Storage • Importation • Receipt • Labelling • Distribution • Secondary packaging • Reverse logistics • Expiry extension South Granville: Headquarters 100-104 Adderley Street West Auburn, NSW, 2144 ~15 minutes’ drive from South Granville Building Area: ~2,100sqm (clearance 9.1m) Services Include: • Clinical trial and biological service expansion • Medical devices • Reverse logistics • Pallet storage Talk to us about your requirements – contact@cryosite.com Auburn: Secondary Facility Results of Meeting Cryosite Limited Annual General Meeting Thursday, 22 October 2026 In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting. Automic GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 Proxy Votes (as at proxy voting close) Poll Results (if applicable) Results Resolution Decided by Show of Hands (S) or Poll (P) FOR AGAINST ABSTAIN PROXY'S DISCRETION FOR AGAINST ABSTAIN OUTCOME 1 Adoption of Remuneration Report P 16,664,862 100.00% 0 0.00% 0 0 0.00% 16,719,862 100.00% 0 0.00% 0 - 2 Issue of Options – Mr. Andrew Kerr P 16,589,862 99.55% 75,000 0.45% 0 0 0.00% 16,644,862 99.55% 75,000 0.45% 0 Carried 3 Issue of Options – Mr. Scott Thomas P 25,896,315 99.71% 75,000 0.29% 0 0 0.00% 25,951,315 99.71% 75,000 0.29% 0 Carried 4 Re-election of Director – Mr. Mark Kerr P 25,971,315 100.00% 0 0.00% 0 0 0.00% 26,026,315 100.00% 0 0.00% 0 Carried 5 Approval of Additional 10% Placement Capacity P 16,588,562 99.55% 75,000 0.45% 1,300 0 0.00% 16,643,562 99.55% 75,000 0.45% 1,300 Carried